6C4C.ZICD-11 MMS 2026-01
Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified
Exclusions from above levels
Sibling codes
6C4C.0– Episode of harmful use of MDMA or related drugs, including MDA6C4C.1– Harmful pattern of use of MDMA or related drugs, including MDA6C4C.2– MDMA or related drug dependence, including MDA6C4C.3– MDMA or related drug intoxication, including MDA6C4C.4– MDMA or related drug withdrawal, including MDA6C4C.5– MDMA or related drug-induced delirium, including MDA6C4C.6– MDMA or related drug-induced psychotic disorder, including MDA6C4C.7– Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA6C4C.Y– Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
Foundation entity
Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] – http://id.who.int/icd/entity/1218193465
Allowed postcoordination axes
Part of: 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders